Nobel Prize 2022

The French author of mostly autobiographical work takes the prestigious books prize for the 'courage and clinical acuity' of her writing.

Previous winners include Bob Dylan, cited for “having created new poetic expressions within the great American song tradition”, and Kazuo Ishiguro “who, in novels of great emotional force, has uncovered the abyss beneath our illusory sense of connection with the world”. Testard said Ernaux’s “literary project has been to write about her life and to get at the truth of it somehow … “Her work is uncompromising and written in plain language, scraped clean,” he continued. Ernaux was born in 1940 and grew up in the small town of Yvetot in Normandy. Reading her is to thoroughly purge yourself of the notion that shame could be a possible outcome of wanting sex.” Ernaux is the first French writer to win the Nobel since Patrick Modiano in 2014.

French writer wins for 'courage and clinical acuity with which she uncovers the roots, estrangements and collective restraints of personal memory'

You can read the full story by Sarah Shaffi here. The Nobel for literature has been turned down twice. Her work is published in the US by Seven Stories Press.

French author Annie Ernaux won the 2022 Nobel Prize in Literature on Thursday for "the courage and clinical acuity" in her largely autobiographical books ...

Former French Culture Minister Roselyne Bachelot wrote on Twitter that Ernaux is "a writer who has put the autobiographical mode in its cold analytical way at the heart of her career. "She's been a very important contributor in terms of memoir and autobiographical work," Whittaker told Reuters. Readers in France said they'd been waiting for Ernaux to win. "I did not imagine at the time that 22 years later, the right to abortion would be challenged," Ernaux told reporters in Paris. "It's a long path that she makes in her life," Swedish Academy member Anders Olsson told Reuters. She has previously said that writing is a political act, opening our eyes to social inequality.

Stockholm (AP) -- French author Annie Ernaux, who mined her own biography to explore life in France since the 1940s, was awarded this year's Nobel Prize in ...

STOCKHOLM (AP) — French author Annie Ernaux, who has mined her own biography to explore life in France since the 1940s, was awarded this year's Nobel Prize ...

The book received numerous awards and honors, and Olsson said it has been called “the first collective autobiography.” The money comes from a bequest left by the prize’s creator, Swedish inventor Alfred Nobel, in 1895. The prizes carry a cash award of 10 million Swedish kronor (nearly $900,000) and will be handed out on Dec. Unlike in previous books, in “The Years,” Ernaux wrote in the third person, calling her character “she” rather than “I”. The Nobel Prize in chemistry was awarded Wednesday to Americans Carolyn R. One of France’s most-garlanded authors and a prominent feminist voice, she expressed surprise at the award, asking a Swedish journalist who reached her by phone: “Are you sure?” Her first book was “Cleaned Out” in 1974. The academy revamped itself but faced more criticism for giving the 2019 literature award to Austria’s Peter Handke, who has been called an apologist for Serbian war crimes. They present uncompromising portraits of sexual encounters, abortion, illness and the deaths of her parents. “And she gives words for these experiences that are very simple and striking. “She writes about things that no one else writes about, for instance her abortion, her jealousy, her experiences as an abandoned lover and so forth. Watch in the player above.

Stanford chemist Carolyn Bertozzi was awarded the Nobel Prize in chemistry for her development of bioorthogonal reactions, which allow scientists to explore ...

She was awarded a MacArthur Fellowship in 1999 at the age of 33, making her one of the youngest to receive that recognition. “Being a woman in science and being trained by her, it was really inspiring to see her speaking about her challenges and I’m so grateful that she paved the way because it’s made it much easier for all of us in the next generations that have followed,” said Sletten, who is now an associate professor at UCLA. Her commitment to mentorship and to increasing diversity in science was recognized with the 2022 Lifetime Mentor Award from the American Association for the Advancement of Science. Bertozzi is a member of the National Academy of Sciences, the National Institute of Medicine, and the National Academy of Inventors; a fellow of the American Academy of Arts and Sciences; and an Investigator of the Howard Hughes Medical Institute since 2000. In her own research, she has helped develop new, lower-cost tests for tuberculosis, more efficient tests for HIV, and a new class of medicines that can clear disease-causing proteins from the surface of cells. “Research at the interface of chemistry and biology has always been where I practice, and having a Nobel Prize in chemical biology is really great for the field,” said Bertozzi, who is also an investigator with the Howard Hughes Medical Institute (HHMI), which has helped fund her work since 2000. In recent years, Bertozzi said, she has grown increasingly interested in applying her decades of experience as a chemist to medicine. “I’m the same person I was at 1 a.m., but I’m realizing that my voice now has a platform, and I’m thinking about how to use that.” For the first time, chemists could actually see how sugars were distributed on the surface of a cell, but the discovery also opened the door to studying chemistry as it actually happens in living things, one of the most complex chemical environments imaginable. Then, after working for years to understand the structure and function of one glycan, Bertozzi had an idea: What if she could attach fluorescent tags to sugar molecules, so that she could literally see where the sugars were in live cells? Since then, her lab and others have used them to answer fundamental questions about the role of sugars in biology, to solve practical problems, such as developing better tests for infectious diseases, and to create a new biological pharmaceutical that can better target tumors, which is now being tested in clinical trials. Bertozzi was recognized for founding the field of bioorthogonal chemistry, a set of chemical reactions that allow researchers to study molecules and their interactions in living things without interfering with natural biological processes.

Carolyn Bertozzi and K. Barry Sharpless, two of this year's Nobel Laureates in Chemistry, share ties to MIT and the Boston area.

The Nobel Prize in Chemistry has been awarded 114 times to 191 Nobel Prize laureates between 1901 and 2022. Sharpless now shares the distinction of having won the Prize in Chemistry twice with one other laureate, Frederick Sanger, who won in 1958 and 1980. Yesterday, the younger Bertozzi revealed that her father was [her first call](https://news.stanford.edu/2022/10/05/carolyn-bertozzi-wins-nobel-chemistry/) upon learning that she had been named a Nobel laureate. Barry Sharpless of the Scripps Research Institute were awarded the prize "for the development of click chemistry and bioorthogonal chemistry." Bertozzi of Stanford University, Morten Meldal of the University of Copenhagen, and K. Both Bertozzi and Sharpless share roots at MIT and the greater Boston area.

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the ...

This work has had an “enormous impact on science,” said Olof Ramström, a member of the Nobel Committee for Chemistry, during the prize announcement. “It’s exciting to be able to do this work in the human body,” says Angela K. Bertozzi was able to lock glowing fluorescent substances onto cell-surface molecules called glycans and to then use this light to track the movement of glycans on the cell. Clicking in these molecules allows chemists to easily change the behavior of a material. The added energy made the alkyne “explode” into a nearby azide, linking the two molecules together. But it’s getting realer by the minute.” Bertozzi is the eighth woman to win the chemistry Nobel.

PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC)...

Acepodia is a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care. These therapies are being developed with Acepodia's antibody-cell conjugation (ACC) platform. 6, 2022 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC) platform technology to address gaps in cancer care, today joins the academic community in congratulating laureates of the 2022 Nobel Prize in Chemistry. The creation of Acepodia's technology platform and its intellectual properties were one of the few companies spun from Bertozzi's lab when our CEO, Sonny Hsiao, Ph.D., worked at Professor Bertozzi's lab when she was a faculty member at UC Berkeley. Acepodia has used "click'' chemistry to click things onto live cells. Carolyn Bertozzi's pioneering work in the development of biorthogonal chemistry which moves click chemistry into living organisms.